AJP - Endo Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 294: E131-E141, 2008. First published November 6, 2007; doi:10.1152/ajpendo.00308.2007
0193-1849/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/1/E131    most recent
00308.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Granado, M.
Right arrow Articles by Villanúa, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Granado, M.
Right arrow Articles by Villanúa, M. A.

GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia

Miriam Granado, Ana Isabel Martín, María López-Menduiña, Asunción López-Calderón, and M. Angeles Villanúa

Department of Physiology, Faculty of Medicine, Complutense University, Madrid, Spain

Submitted 18 May 2007 ; accepted in final form 1 November 2007

It has been reported that growth hormone (GH)-releasing peptide-2 (GHRP-2), a ghrelin receptor agonist, has an anti-inflammatory effect. We investigated whether this GH secretagogue attenuates liver injury in LPS-treated rats. Wistar rats were simultaneously injected (ip) with LPS (1 mg/kg) and/or GHRP-2 (100 µg/kg). Serum levels of aspartate and alanine transaminases were measured as an index of liver damage. Circulating nitrites/nitrates and hepatic IGF-I and TNF-{alpha} were evaluated as possible mediators of GHRP-2 actions. LPS increased serum levels of transaminases and nitrites/nitrates. Moreover, LPS increased hepatic TNF-{alpha} and decreased hepatic IGF-I mRNAs. GHRP-2 administration attenuated the effects of LPS on transaminases, nitrites/nitrates, TNF-{alpha}, and IGF-I in vivo. This GHRP-2 effect does not seem to be due to modifications in food intake, since fasting did not modify serum levels of transaminases, serum nitrites/nitrates, and hepatic TNF-{alpha} mRNA both in vehicle rats and in LPS-injected rats. To elucidate whether GHRP-2 is acting directly on the liver, cocultures of hepatocytes and nonparenchymal cells and monocultures of isolated hepatocytes were incubated with LPS and GHRP-2. The ghrelin receptor agonist prevented an endotoxin-induced increase in transaminases and nitrite/nitrate release as well as in TNF-{alpha} mRNA and increased IGF-I mRNA from cocultures of hepatocytes and nonparenchymal cells, but not from monocultures. In summary, these data indicate that GHRP-2 has a protective effect on the liver in LPS-injected rats that seems to be mediated by IGF-I, TNF-{alpha}, and nitric oxide. Our data also suggest that the anti-inflammatory effect of GHRP-2 in the liver is exerted on nonparenchymal cells.

transaminases; insulin-like growth factor I; nitrites/nitrates; tumor necrosis factor-{alpha}; growth hormone-releasing peptide-2



Address for reprint requests and other correspondence: M. A. Villanúa, Dept. of Physiology, Faculty of Medicine, Complutense Univ., Avda. Complutense s/n, 28040 Madrid, Spain (e-mail: anvi{at}med.ucm.es)




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
V. D. Dixit
Adipose-immune interactions during obesity and caloric restriction: reciprocal mechanisms regulating immunity and health span
J. Leukoc. Biol., October 1, 2008; 84(4): 882 - 892.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.